Substance / Medication

Propylthiouracil

Overview

Active Ingredient
propylthiouracil
RxNorm CUI
8794

Indications

Propylthiouracil is indicated: in patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option. to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole.

Labeler: Bryant Ranch PrepackUpdated: 2025-11-11T00:00:00.000ZFull label on DailyMed

Boxed Warning

FDA Black Box Warning

Severe liver injury and acute liver failure, in some cases fatal, have been reported in patients treated with propylthiouracil. These reports of hepatic reactions include cases requiring liver transplantation in adult and pediatric patients. Propylthiouracil should be reserved for patients who canno

Contraindications

When this intervention should not be used

Propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon Rinat, Blichowski Monica, Koren Gideon · J Obstet Gynaecol Can · 2012
PMID: 23231846Meta-Analysis
Propylthiouracil for alcoholic liver disease.
Fede Giuseppe, Germani Giacomo, Gluud Christian et al. · Cochrane Database Syst Rev · 2011
PMID: 21678335Meta-AnalysisFull text (PMC)
Propylthiouracil for alcoholic liver disease.
Rambaldi A, Gluud C · Cochrane Database Syst Rev · 2005
PMID: 16235302Meta-Analysis
Propylthiouracil for alcoholic liver disease.
Rambaldi A, Gluud C · Cochrane Database Syst Rev · 2002
PMID: 12076451Meta-Analysis
Propylthiouracil quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry: application in a bioequivalence study.
Mendes Gustavo D, Bittencourt Samara, Vespasiano Celso Francisco Pimentel et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2014
PMID: 25146447RCT
Greater energy reduction in 6-n-propylthiouracil (PROP) super-tasters as compared to non-tasters during a lifestyle intervention.
Coletta Adriana, Bachman Jessica, Tepper Beverly J et al. · Eat Behav · 2013
PMID: 23557816RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Propylthiouracil (substance)
SNOMED CT
387203007
UMLS CUI
C0033511
RxNorm CUI
8794
Labeler
Bryant Ranch Prepack

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.